Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CBH Stock Summary
In the News
CEF Weekly Review: Discount Tightening Is Hard (Ask Nuveen)
CEF Weekly Review: Discount Tightening Is Hard (Ask Nuveen)
Weekly CEF Commentary | March 3, 2024 | PDX Makes The Change
Markets were flat, but upcoming events like the jobs report, PMIs, and ECB meeting are important.
CEF Report April 2021: A Complete Round Trip
CEF Report April 2021: A Complete Round Trip
Using Term Funds For A Source Of Cash During Market Sell-Offs
Using Term Funds For A Source Of Cash During Market Sell-Offs
AllianzGI Convertible & Income 2024 Target Term Fund Reports Results for the Fiscal Quarter and Nine Months Ended November 30, 2020
NEW YORK--(BUSINESS WIRE)--AllianzGI Convertible & Income 2024 Target Term Fund (the "Fund") (NYSE: CBH), a diversified closed-end management investment company which seeks to provide a high level of income and to return at least $9.835 per common share (the original net asset value per common share of beneficial interest before deducting offering cost of $0.02 per share) to holders of common shares on or about September 1, 2024, today announced its results for the fiscal quarter and nine m
AllianzGI Closed-End Funds Provide Additional Information on Fund Name Changes
NEW YORK--(BUSINESS WIRE)--AllianzGI Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO), AllianzGI Convertible & Income 2024 Target Term Fund (NYSE: CBH), AllianzGI Convertible & Income Fund (NYSE: NCV), AllianzGI Convertible & Income Fund II (NYSE: NCZ), AllianzGI Diversified Income & Convertible Fund (NYSE: ACV), AllianzGI Dividend, Interest & Premium Strategy Fund (NYSE: NFJ) and AllianzGI Equity & Convertible Income Fund (NYSE: NIE), (each a “Fun
AllianzGI Closed-End Funds Announce Fund Name Changes
NEW YORK--(BUSINESS WIRE)--AllianzGI Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO), AllianzGI Convertible & Income 2024 Target Term Fund (NYSE: CBH), AllianzGI Convertible & Income Fund (NYSE: NCV), AllianzGI Convertible & Income Fund II (NYSE: NCZ), AllianzGI Diversified Income & Convertible Fund (NYSE: ACV), AllianzGI Dividend, Interest & Premium Strategy Fund (NYSE: NFJ) and AllianzGI Equity & Convertible Income Fund (NYSE: NIE) (each a “Fund
AIO, NCV, NCZ, CBH and ACV Declare Monthly Distributions
NEW YORK--(BUSINESS WIRE)--The Boards of Trustees of AllianzGI Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO), AllianzGI Convertible & Income Fund (NYSE: NCV), AllianzGI Convertible & Income Fund II (NYSE: NCZ), AllianzGI Convertible & Income 2024 Target Term Fund (NYSE: CBH), and AllianzGI Diversified Income & Convertible Fund (NYSE: ACV) (each a “Fund” and, collectively, the “Funds”) announced today that they have declared the following distributions o
3 Higher-Yielding Opportunities You Should Exploit
ARDC is a higher risk mix of loans and fixed coupon bonds that remains very cheap. It's being valued like an all loan funds but has more bonds in it. BIT is a long-term holding for many in the YH service but we sold out of it last year after the Aviron Capital LLC debacle.
Real Assets: Looking For Income In All The Right Places?
The Fed may be slower to hike rates than in the past. Lower interest rates suggest fixed-income returns are likely to be less going forward.
CBH Financial details
CBH Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-01-31
Metric | History | 2019-02-28 | 2020-02-29 | 2021-02-28 | 2022-02-28 | 2023-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.5 | 0.72 | 1.44 | 0 | 0 | |
Net income per share | 0.47 | 0.69 | 1.41 | 0 | 0 | |
Operating cash flow per share | 0.56 | 0.55 | 0.55 | 0 | 0 | |
Free cash flow per share | 0.56 | 0.55 | 0.55 | 0 | 0 | |
Cash per share | 0.29 | 0.01 | 0.01 | 0 | 0 | |
Book value per share | 9.65 | 9.85 | 10.71 | 0 | 0 | |
Tangible book value per share | 9.65 | 9.85 | 10.71 | 0 | 0 | |
Share holders equity per share | 9.65 | 9.85 | 10.71 | 0 | 0 | |
Interest debt per share | 3.91 | 3.92 | 3.85 | 0 | 0 | |
Market cap | 165.38M | 166.87M | 185.64M | 0 | 0 | |
Enterprise value | 234.96M | 236.48M | 255.19M | 0 | 69.57M | |
P/E ratio | 19.15 | 13.17 | 7.21 | 0 | 0 | |
Price to sales ratio | 17.99 | 12.69 | 7.07 | 0 | 0 | |
POCF ratio | 16.2 | 16.6 | 18.33 | 0 | 0 | |
PFCF ratio | 16.2 | 16.6 | 18.33 | 0 | 0 | |
P/B Ratio | 0.93 | 0.93 | 0.95 | 0 | 0 | |
PTB ratio | 0.93 | 0.93 | 0.95 | 0 | 0 | |
EV to sales | 25.56 | 17.99 | 9.72 | 0 | 27.52 | |
Enterprise value over EBITDA | 21.66 | 18.67 | 9.65 | 0 | 17.45 | |
EV to operating cash flow | 23.01 | 23.53 | 25.2 | 0 | 5.92 | |
EV to free cash flow | 23.01 | 23.53 | 25.2 | 0 | 5.92 | |
Earnings yield | 0.05 | 0.08 | 0.14 | 0 | 0 | |
Free cash flow yield | 0.06 | 0.06 | 0.05 | 0 | 0 | |
Debt to equity | 0.39 | 0.39 | 0.36 | 0 | 0.41 | |
Debt to assets | 0.27 | 0.28 | 0.26 | 0 | 0.28 | |
Net debt to EBITDA | 6.42 | 5.5 | 2.63 | 0 | 17.45 | |
Current ratio | 1.21 | 0.95 | 0.54 | 0 | 0.56 | |
Interest coverage | 4.91 | 6.57 | 39.02 | 0 | 2.13 | |
Income quality | 1.18 | 0.79 | 0.39 | 0 | 5.57 | |
Dividend Yield | 0.06 | 0.06 | 0.05 | 0 | 0 | |
Payout ratio | 1.17 | 0.8 | 0.39 | 0 | 5.55 | |
Sales general and administrative to revenue | 0.04 | 0.02 | 0.01 | 0 | 0.17 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.1 | 12.4 | 18.43 | 0 | 0 | |
ROIC | 0.04 | 0.05 | 0.1 | 0 | 0.02 | |
Return on tangible assets | 0.03 | 0.05 | 0.1 | 0 | 0.01 | |
Graham Net | -3.17 | -3.87 | -3.97 | 0 | 0 | |
Working capital | 1.61M | -122.19K | -1.81M | 0 | -2.11M | |
Tangible asset value | 177.32M | 179.91M | 195.61M | 0 | 169.38M | |
Net current asset value | -68.53M | -70.18M | -71.97M | 0 | -73.21M | |
Invested capital | 0.39 | 0.39 | 0.36 | 0 | 0.41 | |
Average receivables | 0 | 5.73M | 2.08M | 968.45K | 1.29M | |
Average payables | 0 | 5.09M | 3.17M | 1.95M | 2.41M | |
Average inventory | 0 | 7.31M | 0 | 0 | 0 | |
Days sales outstanding | 366.53 | 61.8 | 26.93 | 0 | 372.8 | |
Days payables outstanding | 1.39K | 432.93 | 0 | 0 | 0 | |
Days of inventory on hand | 2.62K | 0 | 0 | 0 | 0 | |
Receivables turnover | 1 | 5.91 | 13.55 | 0 | 0.98 | |
Payables turnover | 0.26 | 0.84 | 0 | 0 | 0 | |
Inventory turnover | 0.14 | 0 | 0 | 0 | 0 | |
ROE | 0.05 | 0.07 | 0.13 | 0 | 0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-08-31 for Q2
Metric | History | 2021-02-28 | 2021-08-31 | 2022-07-31 | 2023-01-31 | 2023-08-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 69.55M | 69.59M | 69.6M | 69.57M | 0 | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.36 | 0.36 | 0.41 | 0.41 | 0 | |
Debt to assets | 0.26 | 0.26 | 0.29 | 0.28 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 0.54 | 0.36 | 0.58 | 0.56 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | -1.81M | -3.58M | -1.3M | -2.11M | 0 | |
Tangible asset value | 195.61M | 192.03M | 168.3M | 169.38M | 0 | |
Net current asset value | -71.97M | -75.07M | -71.41M | -73.21M | 0 | |
Invested capital | 0.36 | 0.36 | 0.41 | 0.41 | 0 | |
Average receivables | 2.29M | 1.94M | 0 | 2.15M | 1.29M | |
Average payables | 3.3M | 4.77M | 0 | 3.97M | 2.41M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CBH Frequently Asked Questions
What is AllianzGI Convertible & Income 2024 Target Term Fund stock symbol ?
AllianzGI Convertible & Income 2024 Target Term Fund is a US stock , located in New york of Ny and trading under the symbol CBH
What is AllianzGI Convertible & Income 2024 Target Term Fund stock quote today ?
AllianzGI Convertible & Income 2024 Target Term Fund stock price is $8.8 today.
Is AllianzGI Convertible & Income 2024 Target Term Fund stock public?
Yes, AllianzGI Convertible & Income 2024 Target Term Fund is a publicly traded company.